Loading…
Effects of aqueous extract of Ruta graveolens and its ingredients on cytochrome P450, uridine diphosphate (UDP)-glucuronosyltransferase, and reduced nicotinamide adenine dinucleotide (phosphate) (NAD(P)H)-quinone oxidoreductase in mice
Ruta graveolens (the common rue) has been used for various therapeutic purposes, including relief of rheumatism and treatment of circulatory disorder. To elucidate the effects of rue on main drug-metabolizing enzymes, effects of an aqueous extract of the aerial part of rue and its ingredients on cyt...
Saved in:
Published in: | Yàowu shi͡p︡in fenxi 2015-09, Vol.23 (3), p.516-528 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c4685-f7d1bde70bac1aecafbb5c100d21ea5e72919a87e6d8340d73a331fc56345c863 |
---|---|
cites | cdi_FETCH-LOGICAL-c4685-f7d1bde70bac1aecafbb5c100d21ea5e72919a87e6d8340d73a331fc56345c863 |
container_end_page | 528 |
container_issue | 3 |
container_start_page | 516 |
container_title | Yàowu shi͡p︡in fenxi |
container_volume | 23 |
creator | Ueng, Yune-Fang Chen, Chien-Chih Huang, Yu-Ling Lee, I-Jung Yun, Chul-Ho Chen, Yu-Hsuan Huang, Chiung-Chiao |
description | Ruta graveolens (the common rue) has been used for various therapeutic purposes, including relief of rheumatism and treatment of circulatory disorder. To elucidate the effects of rue on main drug-metabolizing enzymes, effects of an aqueous extract of the aerial part of rue and its ingredients on cytochrome P450 (P450/CYP), uridine diphosphate (UDP)-glucuronosyltransferase, and reduced nicotinamide adenine dinucleotide (phosphate) (NAD(P)H):quinone oxidoreductase were studied in C57BL/6JNarl mice. Oral administration of rue extract to males increased hepatic Cyp1a and Cyp2b activities in a dose-dependent manner. Under a 7-day treatment regimen, rue extract (0.5 g/kg) induced hepatic Cyp1a and Cyp2b activities and protein levels in males and females. This treatment increased hepatic UDP-glucuronosyltransferase activity only in males. However, NAD(P)H:quinone oxidoreductase activity remained unchanged. Based on the contents of rutin and furanocoumarins of mouse dose of rue extract, rutin increased hepatic Cyp1a activity and the mixture of furanocoumarins (Fmix) increased Cyp2b activities in males. The mixture of rutin and Fmix increased Cyp1a and Cyp2b activities. These results revealed that rutin and Fmix contributed at least in part to the P450 induction by rue. |
doi_str_mv | 10.1016/j.jfda.2015.03.005 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9351787</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1021949815000502</els_id><sourcerecordid>2049904915</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4685-f7d1bde70bac1aecafbb5c100d21ea5e72919a87e6d8340d73a331fc56345c863</originalsourceid><addsrcrecordid>eNp9kttqGzEQhpfS0rhpX6AXRdAbG7KupF3tAUoh5NAUQmtKcy1kadaWWUuOtDLxM_clMo5T0970Qghm_vlmmPmz7D2jU0ZZ9Wk1XXVGTTllYkqLKaXiRTbinJd5VbHyZTZilLO8LdvmJHsT44rSShQtf52d8KZlrGZslP2-6jrQQyS-I-o-gU-RwMMQlB72oZ9pUGQR1BZ8Dy4S5QyxqLZuEcBYcPtKR_Ru8HoZ_BrIrBT0jKRgjXVAjN0sfdws1QBkfHc5m-SLPukUvPNx12MbFzsIKsLZExqZSYMhzmo_WKfW1gBRBtyB5ZLuARMYHB-5EzL-fn45nk1uJvl9ss6j1D9Y459gA7JxWrK2Gt5mrzrVR3j3_J9md9dXvy5u8tsfX79dnN_muqwakXe1YXMDNZ0rzRRo1c3nQjNKDWegBNS8Za1qaqhMU5TU1IUqCtZpURWl0E1VnGZfDtxNmq_BaNxSUL3cBLtWYSe9svLfjLNLufBb2RaC1U2NgI_PgODxJnGQK5-Cw5klp2Xb4mMCVfyg0sHHGKA7dmBU7g0iV3JvELk3iKSFRINg0Ye_ZzuW_HEECj4fBIAb2loIMmq8M17FBjSKNN7-j_8I34XS2A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2049904915</pqid></control><display><type>article</type><title>Effects of aqueous extract of Ruta graveolens and its ingredients on cytochrome P450, uridine diphosphate (UDP)-glucuronosyltransferase, and reduced nicotinamide adenine dinucleotide (phosphate) (NAD(P)H)-quinone oxidoreductase in mice</title><source>ScienceDirect Journals</source><source>PubMed Central</source><creator>Ueng, Yune-Fang ; Chen, Chien-Chih ; Huang, Yu-Ling ; Lee, I-Jung ; Yun, Chul-Ho ; Chen, Yu-Hsuan ; Huang, Chiung-Chiao</creator><creatorcontrib>Ueng, Yune-Fang ; Chen, Chien-Chih ; Huang, Yu-Ling ; Lee, I-Jung ; Yun, Chul-Ho ; Chen, Yu-Hsuan ; Huang, Chiung-Chiao</creatorcontrib><description>Ruta graveolens (the common rue) has been used for various therapeutic purposes, including relief of rheumatism and treatment of circulatory disorder. To elucidate the effects of rue on main drug-metabolizing enzymes, effects of an aqueous extract of the aerial part of rue and its ingredients on cytochrome P450 (P450/CYP), uridine diphosphate (UDP)-glucuronosyltransferase, and reduced nicotinamide adenine dinucleotide (phosphate) (NAD(P)H):quinone oxidoreductase were studied in C57BL/6JNarl mice. Oral administration of rue extract to males increased hepatic Cyp1a and Cyp2b activities in a dose-dependent manner. Under a 7-day treatment regimen, rue extract (0.5 g/kg) induced hepatic Cyp1a and Cyp2b activities and protein levels in males and females. This treatment increased hepatic UDP-glucuronosyltransferase activity only in males. However, NAD(P)H:quinone oxidoreductase activity remained unchanged. Based on the contents of rutin and furanocoumarins of mouse dose of rue extract, rutin increased hepatic Cyp1a activity and the mixture of furanocoumarins (Fmix) increased Cyp2b activities in males. The mixture of rutin and Fmix increased Cyp1a and Cyp2b activities. These results revealed that rutin and Fmix contributed at least in part to the P450 induction by rue.</description><identifier>ISSN: 1021-9498</identifier><identifier>EISSN: 2224-6614</identifier><identifier>DOI: 10.1016/j.jfda.2015.03.005</identifier><identifier>PMID: 28911711</identifier><language>eng</language><publisher>China (Republic : 1949- ): Elsevier B.V</publisher><subject>Chromatography ; CYP1A protein ; Cytochrome ; Cytochrome P450 ; Drug dosages ; Enzymes ; Females ; Furanocoumarins ; Ingredients ; Males ; Metabolism ; Mice ; Motility ; NAD(P)H:quinone oxidoreductase ; Nicotinamide ; Nicotinamide adenine dinucleotide ; Oral administration ; Original ; Phosphates ; Physiology ; Polyclonal antibodies ; Proteins ; Quinone oxidoreductase ; Rodents ; Ruta graveolens ; Rutin ; Sperm ; Therapeutic applications ; UDP-glucuronosyltransferase ; Uridine</subject><ispartof>Yàowu shi͡p︡in fenxi, 2015-09, Vol.23 (3), p.516-528</ispartof><rights>2015</rights><rights>Copyright © 2015. Published by Elsevier B.V.</rights><rights>Copyright Elsevier Limited Sep 2015</rights><rights>2015 Taiwan Food and Drug Administration 2015</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4685-f7d1bde70bac1aecafbb5c100d21ea5e72919a87e6d8340d73a331fc56345c863</citedby><cites>FETCH-LOGICAL-c4685-f7d1bde70bac1aecafbb5c100d21ea5e72919a87e6d8340d73a331fc56345c863</cites><orcidid>0000-0002-6046-8356</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351787/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1021949815000502$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,3549,27924,27925,45780,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28911711$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ueng, Yune-Fang</creatorcontrib><creatorcontrib>Chen, Chien-Chih</creatorcontrib><creatorcontrib>Huang, Yu-Ling</creatorcontrib><creatorcontrib>Lee, I-Jung</creatorcontrib><creatorcontrib>Yun, Chul-Ho</creatorcontrib><creatorcontrib>Chen, Yu-Hsuan</creatorcontrib><creatorcontrib>Huang, Chiung-Chiao</creatorcontrib><title>Effects of aqueous extract of Ruta graveolens and its ingredients on cytochrome P450, uridine diphosphate (UDP)-glucuronosyltransferase, and reduced nicotinamide adenine dinucleotide (phosphate) (NAD(P)H)-quinone oxidoreductase in mice</title><title>Yàowu shi͡p︡in fenxi</title><addtitle>J Food Drug Anal</addtitle><description>Ruta graveolens (the common rue) has been used for various therapeutic purposes, including relief of rheumatism and treatment of circulatory disorder. To elucidate the effects of rue on main drug-metabolizing enzymes, effects of an aqueous extract of the aerial part of rue and its ingredients on cytochrome P450 (P450/CYP), uridine diphosphate (UDP)-glucuronosyltransferase, and reduced nicotinamide adenine dinucleotide (phosphate) (NAD(P)H):quinone oxidoreductase were studied in C57BL/6JNarl mice. Oral administration of rue extract to males increased hepatic Cyp1a and Cyp2b activities in a dose-dependent manner. Under a 7-day treatment regimen, rue extract (0.5 g/kg) induced hepatic Cyp1a and Cyp2b activities and protein levels in males and females. This treatment increased hepatic UDP-glucuronosyltransferase activity only in males. However, NAD(P)H:quinone oxidoreductase activity remained unchanged. Based on the contents of rutin and furanocoumarins of mouse dose of rue extract, rutin increased hepatic Cyp1a activity and the mixture of furanocoumarins (Fmix) increased Cyp2b activities in males. The mixture of rutin and Fmix increased Cyp1a and Cyp2b activities. These results revealed that rutin and Fmix contributed at least in part to the P450 induction by rue.</description><subject>Chromatography</subject><subject>CYP1A protein</subject><subject>Cytochrome</subject><subject>Cytochrome P450</subject><subject>Drug dosages</subject><subject>Enzymes</subject><subject>Females</subject><subject>Furanocoumarins</subject><subject>Ingredients</subject><subject>Males</subject><subject>Metabolism</subject><subject>Mice</subject><subject>Motility</subject><subject>NAD(P)H:quinone oxidoreductase</subject><subject>Nicotinamide</subject><subject>Nicotinamide adenine dinucleotide</subject><subject>Oral administration</subject><subject>Original</subject><subject>Phosphates</subject><subject>Physiology</subject><subject>Polyclonal antibodies</subject><subject>Proteins</subject><subject>Quinone oxidoreductase</subject><subject>Rodents</subject><subject>Ruta graveolens</subject><subject>Rutin</subject><subject>Sperm</subject><subject>Therapeutic applications</subject><subject>UDP-glucuronosyltransferase</subject><subject>Uridine</subject><issn>1021-9498</issn><issn>2224-6614</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNp9kttqGzEQhpfS0rhpX6AXRdAbG7KupF3tAUoh5NAUQmtKcy1kadaWWUuOtDLxM_clMo5T0970Qghm_vlmmPmz7D2jU0ZZ9Wk1XXVGTTllYkqLKaXiRTbinJd5VbHyZTZilLO8LdvmJHsT44rSShQtf52d8KZlrGZslP2-6jrQQyS-I-o-gU-RwMMQlB72oZ9pUGQR1BZ8Dy4S5QyxqLZuEcBYcPtKR_Ru8HoZ_BrIrBT0jKRgjXVAjN0sfdws1QBkfHc5m-SLPukUvPNx12MbFzsIKsLZExqZSYMhzmo_WKfW1gBRBtyB5ZLuARMYHB-5EzL-fn45nk1uJvl9ss6j1D9Y459gA7JxWrK2Gt5mrzrVR3j3_J9md9dXvy5u8tsfX79dnN_muqwakXe1YXMDNZ0rzRRo1c3nQjNKDWegBNS8Za1qaqhMU5TU1IUqCtZpURWl0E1VnGZfDtxNmq_BaNxSUL3cBLtWYSe9svLfjLNLufBb2RaC1U2NgI_PgODxJnGQK5-Cw5klp2Xb4mMCVfyg0sHHGKA7dmBU7g0iV3JvELk3iKSFRINg0Ye_ZzuW_HEECj4fBIAb2loIMmq8M17FBjSKNN7-j_8I34XS2A</recordid><startdate>20150901</startdate><enddate>20150901</enddate><creator>Ueng, Yune-Fang</creator><creator>Chen, Chien-Chih</creator><creator>Huang, Yu-Ling</creator><creator>Lee, I-Jung</creator><creator>Yun, Chul-Ho</creator><creator>Chen, Yu-Hsuan</creator><creator>Huang, Chiung-Chiao</creator><general>Elsevier B.V</general><general>Food and Drug Administration</general><general>Taiwan Food and Drug Administration</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RQ</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ATCPS</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>L6V</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7S</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PTHSS</scope><scope>Q9U</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-6046-8356</orcidid></search><sort><creationdate>20150901</creationdate><title>Effects of aqueous extract of Ruta graveolens and its ingredients on cytochrome P450, uridine diphosphate (UDP)-glucuronosyltransferase, and reduced nicotinamide adenine dinucleotide (phosphate) (NAD(P)H)-quinone oxidoreductase in mice</title><author>Ueng, Yune-Fang ; Chen, Chien-Chih ; Huang, Yu-Ling ; Lee, I-Jung ; Yun, Chul-Ho ; Chen, Yu-Hsuan ; Huang, Chiung-Chiao</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4685-f7d1bde70bac1aecafbb5c100d21ea5e72919a87e6d8340d73a331fc56345c863</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Chromatography</topic><topic>CYP1A protein</topic><topic>Cytochrome</topic><topic>Cytochrome P450</topic><topic>Drug dosages</topic><topic>Enzymes</topic><topic>Females</topic><topic>Furanocoumarins</topic><topic>Ingredients</topic><topic>Males</topic><topic>Metabolism</topic><topic>Mice</topic><topic>Motility</topic><topic>NAD(P)H:quinone oxidoreductase</topic><topic>Nicotinamide</topic><topic>Nicotinamide adenine dinucleotide</topic><topic>Oral administration</topic><topic>Original</topic><topic>Phosphates</topic><topic>Physiology</topic><topic>Polyclonal antibodies</topic><topic>Proteins</topic><topic>Quinone oxidoreductase</topic><topic>Rodents</topic><topic>Ruta graveolens</topic><topic>Rutin</topic><topic>Sperm</topic><topic>Therapeutic applications</topic><topic>UDP-glucuronosyltransferase</topic><topic>Uridine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ueng, Yune-Fang</creatorcontrib><creatorcontrib>Chen, Chien-Chih</creatorcontrib><creatorcontrib>Huang, Yu-Ling</creatorcontrib><creatorcontrib>Lee, I-Jung</creatorcontrib><creatorcontrib>Yun, Chul-Ho</creatorcontrib><creatorcontrib>Chen, Yu-Hsuan</creatorcontrib><creatorcontrib>Huang, Chiung-Chiao</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Career & Technical Education Database</collection><collection>Agricultural Science Collection</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science & Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central</collection><collection>Agricultural & Environmental Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Engineering Collection</collection><collection>Agricultural Science Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Engineering Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>Engineering Collection</collection><collection>ProQuest Central Basic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Yàowu shi͡p︡in fenxi</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ueng, Yune-Fang</au><au>Chen, Chien-Chih</au><au>Huang, Yu-Ling</au><au>Lee, I-Jung</au><au>Yun, Chul-Ho</au><au>Chen, Yu-Hsuan</au><au>Huang, Chiung-Chiao</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects of aqueous extract of Ruta graveolens and its ingredients on cytochrome P450, uridine diphosphate (UDP)-glucuronosyltransferase, and reduced nicotinamide adenine dinucleotide (phosphate) (NAD(P)H)-quinone oxidoreductase in mice</atitle><jtitle>Yàowu shi͡p︡in fenxi</jtitle><addtitle>J Food Drug Anal</addtitle><date>2015-09-01</date><risdate>2015</risdate><volume>23</volume><issue>3</issue><spage>516</spage><epage>528</epage><pages>516-528</pages><issn>1021-9498</issn><eissn>2224-6614</eissn><abstract>Ruta graveolens (the common rue) has been used for various therapeutic purposes, including relief of rheumatism and treatment of circulatory disorder. To elucidate the effects of rue on main drug-metabolizing enzymes, effects of an aqueous extract of the aerial part of rue and its ingredients on cytochrome P450 (P450/CYP), uridine diphosphate (UDP)-glucuronosyltransferase, and reduced nicotinamide adenine dinucleotide (phosphate) (NAD(P)H):quinone oxidoreductase were studied in C57BL/6JNarl mice. Oral administration of rue extract to males increased hepatic Cyp1a and Cyp2b activities in a dose-dependent manner. Under a 7-day treatment regimen, rue extract (0.5 g/kg) induced hepatic Cyp1a and Cyp2b activities and protein levels in males and females. This treatment increased hepatic UDP-glucuronosyltransferase activity only in males. However, NAD(P)H:quinone oxidoreductase activity remained unchanged. Based on the contents of rutin and furanocoumarins of mouse dose of rue extract, rutin increased hepatic Cyp1a activity and the mixture of furanocoumarins (Fmix) increased Cyp2b activities in males. The mixture of rutin and Fmix increased Cyp1a and Cyp2b activities. These results revealed that rutin and Fmix contributed at least in part to the P450 induction by rue.</abstract><cop>China (Republic : 1949- )</cop><pub>Elsevier B.V</pub><pmid>28911711</pmid><doi>10.1016/j.jfda.2015.03.005</doi><tpages>13</tpages><orcidid>https://orcid.org/0000-0002-6046-8356</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1021-9498 |
ispartof | Yàowu shi͡p︡in fenxi, 2015-09, Vol.23 (3), p.516-528 |
issn | 1021-9498 2224-6614 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9351787 |
source | ScienceDirect Journals; PubMed Central |
subjects | Chromatography CYP1A protein Cytochrome Cytochrome P450 Drug dosages Enzymes Females Furanocoumarins Ingredients Males Metabolism Mice Motility NAD(P)H:quinone oxidoreductase Nicotinamide Nicotinamide adenine dinucleotide Oral administration Original Phosphates Physiology Polyclonal antibodies Proteins Quinone oxidoreductase Rodents Ruta graveolens Rutin Sperm Therapeutic applications UDP-glucuronosyltransferase Uridine |
title | Effects of aqueous extract of Ruta graveolens and its ingredients on cytochrome P450, uridine diphosphate (UDP)-glucuronosyltransferase, and reduced nicotinamide adenine dinucleotide (phosphate) (NAD(P)H)-quinone oxidoreductase in mice |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T04%3A07%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20of%20aqueous%20extract%20of%20Ruta%20graveolens%20and%20its%20ingredients%20on%20cytochrome%20P450,%20uridine%20diphosphate%20(UDP)-glucuronosyltransferase,%20and%20reduced%20nicotinamide%20adenine%20dinucleotide%20(phosphate)%20(NAD(P)H)-quinone%20oxidoreductase%20in%20mice&rft.jtitle=Ya%CC%80owu%20shi%CD%A1p%EF%B8%A1in%20fenxi&rft.au=Ueng,%20Yune-Fang&rft.date=2015-09-01&rft.volume=23&rft.issue=3&rft.spage=516&rft.epage=528&rft.pages=516-528&rft.issn=1021-9498&rft.eissn=2224-6614&rft_id=info:doi/10.1016/j.jfda.2015.03.005&rft_dat=%3Cproquest_pubme%3E2049904915%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4685-f7d1bde70bac1aecafbb5c100d21ea5e72919a87e6d8340d73a331fc56345c863%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2049904915&rft_id=info:pmid/28911711&rfr_iscdi=true |